Nureca Share Price: What Could the Next 3 Years Look Like?

The Nureca share price forecast for the next 3 years is a question on many investors’ minds as the stock trades at Rs 290, within a 52 week range of Rs 200 to Rs 344. This article lays out a scenario based Nureca share price outlook for 2027, 2028 and 2030, built on the company’s fundamentals, sector trends and the key risks that could change the trajectory. Rather than a single number, the focus here is on the range of outcomes and the assumptions behind each one.

Click Here – Get Free Investment Predictions

Nureca Company Overview

Nureca manufactures and markets home healthcare and wellness devices under the Dr Trust brand, including blood pressure monitors, glucometers and fitness equipment. Understanding the business model is the first step in framing any credible Nureca share price forecast, because the durability of earnings ultimately decides where the stock trades.

Company	Nureca
NSE Ticker	NURECA
CMP	Rs 290
52 Week High	Rs 344
52 Week Low	Rs 200
Market Cap	Rs 278 Cr
Stock PE	132
Book Value	Rs 189
ROE	1.12%
ROCE	3.3%
Dividend Yield	0%

Where Does Nureca Share Price Stand Today?

The stock currently trades about 16 percent below its 52 week high of Rs 344, which means the market has already tempered some of its optimism. For anyone building a Nureca share price forecast, this correction matters for the Nureca share price forecast starting point, because entry valuations have a large bearing on 3 year returns.

At the current price, Nureca commands a market capitalisation of Rs 278 Cr and trades at a price to earnings multiple of 132. The company generates a return on equity of 1.12% and a return on capital employed of 3.3%, which places it in the category of businesses with a recovering profitability profile. These numbers anchor the Nureca share price forecast scenarios that follow. How the broader Nifty 50 index trades over this period will also influence the multiple investors are willing to assign to the stock.

Nureca Share Price Forecast: Key Growth Drivers for the Next 3 Years

Four forces are likely to shape the Nureca share price forecast between now and 2030, and together they explain most of the dispersion in this Nureca share price forecast. Each is discussed below with its likely direction of impact.

Earnings Trajectory and Return Ratios

Stock prices ultimately follow earnings. With a recovering profitability profile at present, the pace at which profits compound over FY27 to FY30 will be the single biggest determinant of the Nureca share price forecast actually playing out. Consistent earnings delivery tends to expand valuation multiples, while misses compress them quickly.

Consumer Durables Penetration Story

Room air conditioner penetration in India remains far below global averages, implying a long growth runway. Brands like Nureca with manufacturing scale and distribution reach can grow volumes in double digits across cycles.

Within the space, investors often benchmark Nureca against peers such as Morepen Laboratories, Ksolves India peer IZMO and Ice Make Refrigeration on growth and valuations before forming a view on the Nureca share price forecast.

Company Specific Catalysts

The bull case for Nureca rests on rising demand for home healthcare devices as health awareness and preventive care adoption grows. If these play out on schedule, the Nureca share price forecast for 2030 could gravitate toward the upper end of the scenario range discussed below.

Macro Environment and Liquidity

The RBI rate cycle, FII flows into Indian equities and overall market valuations will influence the multiple investors are willing to pay. A benign macro backdrop supports the optimistic end of any Nureca share price forecast, while global risk aversion would do the opposite to the Nureca share price outlook.

Nureca Share Price Forecast 2027, 2028 and 2030: Scenario Analysis

The table below presents a scenario based Nureca share price forecast using compounded annual growth assumptions applied to the current market price of Rs 290. These are illustrative ranges, not point predictions, and actual outcomes can fall outside them.

Year	Bear Case	Base Case	Bull Case	Assumption
2027	Rs 300	Rs 325	Rs 355	2% to 14% CAGR on CMP
2028	Rs 305	Rs 350	Rs 400	2% to 14% CAGR on CMP
2030	Rs 315	Rs 410	Rs 525	2% to 14% CAGR on CMP

In the base case scenario of this Nureca share price forecast, the 2030 level works out to roughly Rs 410, implying steady compounding from today’s levels. The bull case of Rs 525 assumes rising demand for home healthcare devices as health awareness and preventive care adoption grows delivers ahead of expectations, while the bear case of Rs 315 captures a scenario where growth stalls. That is an outcome band of about 9 percent to 81 percent over the period.

Consult a SEBI Registered Investment Advisor Before Acting on Any Forecast

Bull Case vs Bear Case for Nureca Share Price

The Bull Case

The optimistic Nureca share price forecast assumes rising demand for home healthcare devices as health awareness and preventive care adoption grows. Combined with supportive sector conditions, this could lift both earnings and the valuation multiple, pushing the stock toward Rs 525 by 2030.

The Bear Case

The cautious view centres on the fact that competitive intensity from other home healthcare device brands and import dependence on components are key risks. If these pressures dominate, the Nureca share price forecast would skew toward the lower band and the stock could stagnate near Rs 315 even by 2030, underperforming broader indices.

Key Risks That Could Change the Nureca Share Price Outlook

• Execution risk: Delays in strategy execution or capacity plans would push the earnings trajectory below the base case assumed in this Nureca share price forecast.
• Valuation risk: At a PE of 132, any earnings disappointment can trigger sharp multiple compression before fundamentals stabilise.
• Sector risk: Competitive intensity from other home healthcare device brands and import dependence on components are key risks.
• Macro risk: A global slowdown, adverse FII flows or unexpected rate moves would compress equity valuations across the market.
• Regulatory risk: Policy, tax or compliance changes affecting the sector can alter the earnings outlook with little warning.

Is Nureca Worth Watching for the Long Term?

For long term investors, the relevant question is not just where the Nureca share price forecast lands in 2030 or what any single Nureca share price forecast says today, but whether the business can compound capital through cycles. The company’s positioning around rising demand for home healthcare devices as health awareness and preventive care adoption grows gives it a credible growth story, while the risks outlined above define what must be monitored each quarter.

Investors should track quarterly earnings, management commentary and sector data rather than anchoring to any single number from a Nureca share price outlook. Historically, staying focused on business fundamentals has served investors better than chasing price targets, and consulting a SEBI registered advisor before investing remains the prudent approach.

Download the Univest iOS App or Univest Android App to track Nureca share price live.

Conclusion

The Nureca share price forecast for the next 3 years spans Rs 315 to Rs 525 by 2030 under the scenarios discussed, with a base case near Rs 410. Any credible Nureca share price forecast must be updated as facts change, and the path will be decided by earnings delivery, rising demand for home healthcare devices as health awareness and preventive care adoption grows and the broader market environment. Treat these ranges as a framework for thinking, not a promise of outcomes, and revisit the assumptions as new results come in. Consult a SEBI registered investment advisor before making any investment decision.

What is the Nureca share price forecast for the next 3 years?

Ans. The Nureca share price forecast for the next 3 years is scenario based rather than a single number. By 2030, the illustrative range spans Rs 315 in the bear case to Rs 525 in the bull case, with a base case near Rs 410, depending on earnings delivery and market conditions.

What is the Nureca share price forecast for 2027?

Ans. For 2027, the scenario range works out to Rs 300 to Rs 355, with a base case around Rs 325. This assumes compounding on the current price of Rs 290 and is illustrative, not a guaranteed outcome.

What is the Nureca share price forecast for 2028?

Ans. The 2028 scenario range is Rs 305 to Rs 400, with the base case near Rs 350. Actual levels will depend on earnings growth, sector trends and overall market valuations at the time.

What is the current share price of Nureca?

Ans. Nureca currently trades at around Rs 290 on the NSE, within a 52 week range of Rs 200 to Rs 344. Prices change continuously during market hours, so check live quotes before acting.

Is Nureca a good stock for the long term?

Ans. Nureca has a credible long term story built on rising demand for home healthcare devices as health awareness and preventive care adoption grows, but it also carries risks since competitive intensity from other home healthcare device brands and import dependence on components are key risks. Long term suitability depends on your risk profile and portfolio, so consult a SEBI registered investment advisor before investing.

What is the Nureca share price outlook for 2030?

Ans. The Nureca share price outlook for 2030 spans Rs 315 to Rs 525 across bear and bull scenarios. Where the stock actually lands will be driven by profit growth, valuation multiples and macro conditions closer to that date.

What are the key risks to the Nureca share price forecast?

Ans. The main risks are execution delays, valuation compression from the current PE of 132, sector specific pressures, macro shocks and regulatory changes. Any of these can push the stock below the base case scenario discussed in this article.